Cost-effectiveness analysis of general anaesthesia versus local anaesthesia for carotid surgery (GALA Trial)

被引:42
|
作者
Gomes, M. [2 ]
Soares, M. O. [1 ]
Dumville, J. C.
Lewis, S. C. [3 ]
Torgerson, D. J.
Bodenham, A. R. [4 ]
Gough, M. J. [5 ]
Warlow, C. P. [3 ]
机构
[1] Univ York, Ctr Hlth Econ, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England
[2] Univ York, Dept Econ & Related Studies, York YO10 5DD, N Yorkshire, England
[3] Univ Edinburgh, Div Clin Neurosci, Edinburgh, Midlothian, Scotland
[4] Leeds Gen Infirm, Dept Anaesthesia, Leeds, W Yorkshire, England
[5] Leeds Gen Infirm, Vasc Surg Unit, Leeds, W Yorkshire, England
关键词
EFFECTIVENESS ACCEPTABILITY CURVES; ASYMPTOMATIC PATIENTS; REGRESSION METHODS; RANDOMIZED-TRIAL; ENDARTERECTOMY; STENOSIS;
D O I
10.1002/bjs.7110
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Health outcomes and costs are both important when deciding whether general (GA) or local (LA) anaesthesia should be used during carotid endarterectomy. The aim of this study was to assess the cost-effectiveness of carotid endarterectomy under LA or GA in patients with symptomatic or asymptomatic carotid stenosis for whom surgery was advised. Methods: Using patient-level data from a large, multinational, randomized controlled trial (GALA Trial) time free from stroke, myocardial infarction or death, and costs incurred were evaluated. The cost-effectiveness outcome was incremental cost per day free from an event, within a time horizon of 30 days. Results: A patient undergoing carotid endarterectomy under LA incurred fewer costs (mean difference 178) pound and had a slightly longer event-free survival (difference 0.16 days, but the 95 per cent confidence limits around this estimate were wide) compared with a patient who had GA. Existing uncertainty did not have a significant impact on the decision to adopt LA, over a wide range of willingness-to-pay values. Conclusion: If cost-effectiveness was considered in the decision to adopt GA or LA for carotid endarterectomy, given the evidence provided by this study, LA is likely to be the favoured treatment for patients for whom either anaesthetic approach is clinically appropriate.
引用
收藏
页码:1218 / 1225
页数:8
相关论文
共 50 条
  • [31] Cost-Effectiveness of Tight Control of Inflammation in Early Psoriatic Arthritis: Economic Analysis of a Multicenter Randomized Controlled Trial
    O'Dwyer, John L.
    Meads, David M.
    Hulme, Claire T.
    Mcparland, Lucy
    Brown, Sarah
    Coates, Laura C.
    Moverley, Anna R.
    Emery, Paul
    Conaghan, Philip G.
    Helliwell, Philip S.
    ARTHRITIS CARE & RESEARCH, 2018, 70 (03) : 462 - 468
  • [32] Endoscopic Biliary Stenting Versus Percutaneous Transhepatic Biliary Stenting in Advanced Malignant Biliary Obstruction: Cost-effectiveness Analysis
    Sun, Xin Rong
    Tang, Cheng Wu
    Lu, Wen Ming
    Xu, Yong Qiang
    Feng, Wen Ming
    Rao, Yin
    Zheng, Yin Yuan
    HEPATO-GASTROENTEROLOGY, 2014, 61 (131) : 563 - 566
  • [33] Cost-effectiveness of steroid (methylprednisolone) injections versus anaesthetic alone for the treatment of Morton's neuroma: economic evaluation alongside a randomised controlled trial (MortISE trial)
    Edwards, Rhiannon Tudor
    Yeo, Seow Tien
    Russell, Daphne
    Thomson, Colin E.
    Beggs, Ian
    Gibson, J. N. Alastair
    McMillan, Diane
    Martin, Denis J.
    Russell, Ian T.
    JOURNAL OF FOOT AND ANKLE RESEARCH, 2015, 8
  • [34] Reference-based multiple imputation for missing data sensitivity analyses in trial-based cost-effectiveness analysis
    Leurent, Baptiste
    Gomes, Manuel
    Cro, Suzie
    Wiles, Nicola
    Carpenter, James R.
    HEALTH ECONOMICS, 2020, 29 (02) : 171 - 184
  • [35] The Impact of Fewer Hip Fractures with Risedronate Versus Alendronate in the First Year of Treatment: Modeled German Cost-Effectiveness Analysis
    Thompson, Melissa
    Pasquale, Margaret
    Grima, Daniel
    Moehrke, Werner
    Kruse, Hans Peter
    VALUE IN HEALTH, 2010, 13 (01) : 46 - 54
  • [36] Transcatheter Aortic Valve Implantation versus Surgical Aortic Valve Replacement: Meta-Analysis of Clinical Outcomes and Cost-Effectiveness
    Cao, Christopher
    Liou, Kevin P.
    Pathan, Faraz K.
    Virk, Sohaib
    McMonnies, Robert
    Wolfenden, Hugh
    Indraratna, Praveen
    CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (13) : 1965 - 1977
  • [37] Partially covered self-expandable metal stents versus polyethylene stents for malignant biliary obstruction: A cost-effectiveness analysis
    Barkun, Alan N.
    Adam, Viviane
    Martel, Myriam
    AlNaamani, Khalid
    Moses, Peter L.
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 29 (07): : 377 - 383
  • [38] Cost-Effectiveness Analysis of SBRT Versus IMRT: An Emerging Initial Radiation Treatment Option for Organ-Confined Prostate Cancer
    Hodges, Joseph C.
    Lotan, Yair
    Boike, Thomas P.
    Benton, Rhonda
    Barrier, Alyson
    Timmerman, Robert D.
    AMERICAN JOURNAL OF MANAGED CARE, 2012, 18 (05) : E186 - E192
  • [39] A trial-based cost-effectiveness analysis of antibiotic prescription strategies for non-complicated respiratory tract infections in children
    Mas-Dalmau, Gemma
    Perez-Lacasta, Maria Jose
    Alonso-Coello, Pablo
    Gorrotxategi-Gorrotxategi, Pedro
    Arguelles-Prendes, Emma
    Espinazo-Ramos, Oscar
    Valls-Duran, Teresa
    Gonzalo-Alonso, Maria Encarnacion
    Cortes-Viana, Maria Pilar
    Menendez-Bada, Tatiana
    Vazquez-Fernandez, Marta Esther
    Perez-Hernandez, Ana Isabel
    Munoz-Ortiz, Laura
    Villanueva-Lopez, Carmen
    Little, Paul
    de la Poza-Abad, Mariam
    Carles-Lavila, Misericordia
    BMC PEDIATRICS, 2023, 23 (01)
  • [40] Cost-Effectiveness Analysis of Cytoreductive Surgery and HIPEC Compared With Systemic Chemotherapy in Isolated Peritoneal Carcinomatosis From Metastatic Colorectal Cancer
    Hamilton, Trevor D.
    MacNeill, Andrea J.
    Lim, Howard
    Hunink, M. G. Myriam
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (04) : 1110 - 1117